Literature DB >> 7621584

IL-13 results in differential regulation of the complement proteins C3 and factor B in tumour necrosis factor (TNF)-stimulated fibroblasts.

Y Katz1, D Stav, J Barr, J H Passwell.   

Abstract

IL-13, like IL-4, a product of activated T cells, has multiple biological actions, primarily on B cells and monocytes. The purpose of the present study was to compare the effects of IL-13 with those of IL-4 on the synthesis of complement proteins in fibroblasts. Dermal fibroblasts were developed from skin biopsies. Confluent monolayers were stimulated with the relevant cytokine or combinations of cytokines and biosynthetically labelled with 35S-methionine. The specific proteins were analysed using immunoprecipitation and SDS-PAGE. Addition of IL-13 to fibroblast cultures treated with TNF-alpha resulted in a dose-dependent increase in C3 protein biosynthesis and a concomitant down-regulation of factor B protein biosynthesis. In TNF-stimulated fibroblasts, the addition of IL-13, 100 ng/ml, induced a 2.45-fold increase in the synthesis of C3, while in the same cells under identical conditions the synthesis of factor B was only 42% of the level without IL-13. Similar effects of IL-13 were noted on IL-1-treated fibroblasts. These effects were specific for C3 and factor B, and no alteration of the constitutive or TNF-induced synthesis of C1s or C1 inhibitor proteins was observed. IL-13 altered the synthesis of C3 and factor B proteins also in fibroblasts stimulated with interferon-gamma (IFN-gamma) in addition to TNF, in the same direction as it did in cells stimulated with TNF alone. IL-13 has similar effects to those of IL-4 on the synthesis of C and factor B in TNF- and IL-1-stimulated fibroblasts. The observed effects of IL-13 are IL-4-independent, as anti-IL-4 antibody abrogates IL-4-induced effects, but has no effect on IL-13-induced responses. This interaction between different cytokines on the synthesis of proinflammatory and immunoregulatory proteins may have significance, particularly at local sites of inflammation, and may affect the synthesis of complement proteins in inflamed joint as in rheumatoid arthritis.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7621584      PMCID: PMC1553288          DOI: 10.1111/j.1365-2249.1995.tb02291.x

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  25 in total

1.  Inhibition of the production of proinflammatory cytokines and immunoglobulins by interleukin-4 in an ex vivo model of rheumatoid synovitis.

Authors:  P Miossec; J Briolay; J Dechanet; J Wijdenes; H Martinez-Valdez; J Banchereau
Journal:  Arthritis Rheum       Date:  1992-08

Review 2.  The role of C3 in the immune response.

Authors:  A Erdei; G Füst; J Gergely
Journal:  Immunol Today       Date:  1991-09

Review 3.  Complement C3: a molecular mosaic of binding sites.

Authors:  Z Fishelson
Journal:  Mol Immunol       Date:  1991 Apr-May       Impact factor: 4.407

4.  Growth control of activated, synchronized murine B cells by the C3d fragment of human complement.

Authors:  F Melchers; A Erdei; T Schulz; M P Dierich
Journal:  Nature       Date:  1985 Sep 19-25       Impact factor: 49.962

5.  Synovial fibroblast-like cells synthesize seven proteins of the complement system.

Authors:  Y Katz; R C Strunk
Journal:  Arthritis Rheum       Date:  1988-11

6.  Synthesis and regulation of C1 inhibitor in human skin fibroblasts.

Authors:  Y Katz; R C Strunk
Journal:  J Immunol       Date:  1989-03-15       Impact factor: 5.422

7.  Enhanced synthesis of factor B induced by tumor necrosis factor in human skin fibroblasts is decreased by IL-4.

Authors:  Y Katz; R C Strunk
Journal:  J Immunol       Date:  1990-06-15       Impact factor: 5.422

8.  IL-10 is produced by subsets of human CD4+ T cell clones and peripheral blood T cells.

Authors:  H Yssel; R De Waal Malefyt; M G Roncarolo; J S Abrams; R Lahesmaa; H Spits; J E de Vries
Journal:  J Immunol       Date:  1992-10-01       Impact factor: 5.422

Review 9.  Interleukin 13, an interleukin 4-like cytokine that acts on monocytes and B cells, but not on T cells.

Authors:  G Zurawski; J E de Vries
Journal:  Immunol Today       Date:  1994-01

10.  Generation of interleukin 4 (IL-4)-producing cells in vivo and in vitro: IL-2 and IL-4 are required for in vitro generation of IL-4-producing cells.

Authors:  G Le Gros; S Z Ben-Sasson; R Seder; F D Finkelman; W E Paul
Journal:  J Exp Med       Date:  1990-09-01       Impact factor: 14.307

View more
  2 in total

1.  IL-17 regulates gene expression and protein synthesis of the complement system, C3 and factor B, in skin fibroblasts.

Authors:  Y Katz; O Nadiv; M J Rapoport; M Loos
Journal:  Clin Exp Immunol       Date:  2000-04       Impact factor: 4.330

2.  Biomarkers of systemic inflammation in farmers with musculoskeletal disorders; a plasma proteomic study.

Authors:  Bijar Ghafouri; Anders Carlsson; Sara Holmberg; Anders Thelin; Christer Tagesson
Journal:  BMC Musculoskelet Disord       Date:  2016-05-10       Impact factor: 2.362

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.